Good morning. Amazon denies a reported tariff label plan after the White House blasted it as “hostile.” Novo Nordisk is ...

Novo Nordisk A/S faces challenges in the obesity market, but new trials and innovations offer hope. Read more on NVO stock ...

The Strategy posted positive absolute returns but slightly trailed its benchmark as detractors in consumer staples overcame ...

Hundreds of thousands of people flocked to these compounding firms when they didn't have enough money to afford the costly ...

Wegovy's launch in Thaliand comes nearly a month after Eli Lilly launched its obesity management drug Mounjaro in India at ...

From her home on Louisiana's "Cancer Alley," Lydia Gerard looks down at her 8-month-old great-granddaughter and wonders if ...

GE Vernova reported first-quarter revenue that beat analysts' estimates on the back of strength in its power and ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ ...

The move gives Novo Nordisk and Eli Lilly a bit more time of having the only patent-protected GLP-1 drugs on the market. Viking Therapeutics moves toward the head of the pack to become No. 3 ...

Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Co., Novo Nordisk A/S and PepsiCo, Inc., as well as two micro-cap stocks Genie Energy Ltd ...

Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Co., Novo Nordisk A/S and PepsiCo, Inc., as well as two micro-cap stocks Genie Energy Ltd. and ...